Family-owned health supplements maker and distributor Homart Pharmaceuticals takes a strategic stake in ASX-listed Wellnex Life. This makes if the second public listed company that Homart invests in this year 2022.
Homart’s set to tip in $3 million into a $6 million deal, with funds raised to progress the group’s plans to get into over-the-counter medicinal cannabis. Homart Pharmaceuticals makes and distributes nutraceutical and dairy products, with about 150 employees in Australia. Read more about the investure at: Distributor Homart Pharma takes stake in Wellnex Life
#homartaustralia #investment #ASX #capitalrasising #3million